Generali Asset Management SPA SGR Has $6.07 Million Stock Holdings in Synopsys, Inc. $SNPS

Generali Asset Management SPA SGR lowered its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 17.4% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,311 shares of the semiconductor company’s stock after selling 2,594 shares during the period. Generali Asset Management SPA SGR’s holdings in Synopsys were worth $6,074,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Independence Bank of Kentucky raised its stake in Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares in the last quarter. Princeton Global Asset Management LLC grew its holdings in shares of Synopsys by 481.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 53 shares during the last quarter. AlphaQuest LLC increased its position in Synopsys by 423.1% during the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 55 shares in the last quarter. DiNuzzo Private Wealth Inc. lifted its stake in Synopsys by 266.7% in the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 77 shares of the semiconductor company’s stock valued at $38,000 after purchasing an additional 56 shares during the last quarter. Finally, Whipplewood Advisors LLC lifted its stake in Synopsys by 203.7% in the 2nd quarter. Whipplewood Advisors LLC now owns 82 shares of the semiconductor company’s stock valued at $42,000 after purchasing an additional 55 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys Stock Up 2.3%

Shares of SNPS opened at $480.42 on Friday. The stock’s 50-day moving average price is $439.30 and its two-hundred day moving average price is $503.01. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a market capitalization of $91.91 billion, a PE ratio of 60.13, a PEG ratio of 3.91 and a beta of 1.12. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm’s revenue was up 37.8% compared to the same quarter last year. During the same period last year, the company earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity

In other news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on SNPS. Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and lowered their price target for the stock from $605.00 to $560.00 in a report on Tuesday, December 9th. Mizuho reduced their price objective on Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a research report on Thursday, September 11th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Baird R W lowered Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Finally, JPMorgan Chase & Co. upped their price objective on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Eleven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average target price of $562.13.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.